NEW Seminar Series: State-of-the-art Topics in Vaccinology

Featured News
Flyer of Featured Presentation by Dr. Nadine Rouphael, Executive Director of the Hope Clinic at the Emory Vaccine Center

You are invited to attend the first featured presentation in the "State-of-the-Art Topics in Vaccinology" Seminar Series on Tuesday January 28, 2025 at 2 pm. Dr. Nadine Rouphael, Executive Director of the Hope Clinic at the Emory Vaccine Center, will be presenting on Systems Vaccinology: Navigating the Future of Personalized Immunity and Next-Generation Vaccines.

This will be an in-person-only event and registration is required. 

This event will be held at the George Washington University School Science and Engineering in Lehman Auditorium (Room B1220) at 800 22nd ST NW, Washington, DC 20052. 

Click here to register!
vaccine

Latest News

This is an HIV antibody with a yellow core and pink outer shell.
Targeting HIV broadly neutralizing antibody precursors with precision in humans.
A protective HIV vaccine will need to induce broadly neutralizing antibodies (bnAbs) in humans, but priming rare bnAb precursor B cells has been challenging. This study provides proof-of-concept for Env trimer-based GT approaches to activate bnAb precursors and induce affinity maturation on the…
Picture of antibodies.
HIV vaccine using mRNA-encoded nanoparticles showed to be safe and well-tolerated
The GW VRU participated in IAVI-G002 as a clinical site for a phase 1 human clinical trial. This study evaluated the safety and immunogenicity of mRNA-encoded nanoparticles as priming immunogens and first-boosting immunogens (IAVI-G002).
Latest Publication:
The GW VRU is proud to announce our newest publication to describe the development of a new Na-GST-1/Alhydrogel hookworm vaccine. This study showed promising results and can be read at the link below: